EU-ACT together with CADAP, in close consultation with EMCDDA, organised a regional expert workshop on “New Psychoactive Substances: Legal and Practical Challenges” in Almaty, Kazakhstan from 24th to 26th October 2018.
EU-ACT together with CADAP (Central Asia Drug Action Program), in close consultation with EMCDDA (European Monitoring Centre for Drugs and Drug Addiction), organised a regional expert workshop on “New Psychoactive Substances (NPS): Legal and Practical Challenges” in Almaty, Kazakhstan from 24th to 26th October 2018.
The workshop took place in the premises of the Central Asian Regional Information and Coordination Centre (CARICC) in Almaty, Kazakhstan.
The new psychoactive substances phenomenon continues to represent a considerable public health challenge. The overall availability of new psychoactive substances continues to grow. While legal, judicial, law enforcement and health systems are struggling to face this phenomenon, the long-term consequences of new drugs abuse are still unknown.
The workshop explored these challenges in the Central Asia region, together with the responses that European agencies have adopted to support its member states to face the hardships represented by NPS.